Skip to main content
. 2021 Jun 16;134(13):1610–1615. doi: 10.1097/CM9.0000000000001492

Figure 1.

Figure 1

The flow diagram of the impact of EDA on PND and peripheral blood CXCL-13 levels in elderly patients with hip replacement. CON: Group control; CXCL-13: C-X-C motif chemokine ligand 13; EDA: Group edaravone; ICU: Intensive care unit; IL-6: Interleukin-6; PND: Perioperative neurocognitive disorders.